Unexplained recurrent miscarriages: Predictive value of immune biomarkers and immunomodulatory therapies for live birth
- 18 December 2021
- journal article
- letter
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 87 (2) , e13512
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy lossThe Lancet, 2021
- Recurrent miscarriage: evidence to accelerate actionThe Lancet, 2021
- Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birthAmerican Journal of Reproductive Immunology, 2021
- Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activityJournal of Cellular and Molecular Medicine, 2021
- Prednisone improves pregnancy outcome in repeated implantation failure by enhance regulatory T cells biasJournal of Reproductive Immunology, 2021
- The pathogenic role of autoantibodies in recurrent pregnancy lossAmerican Journal of Reproductive Immunology, 2019
- The Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro FertilizationAmerican Journal of Reproductive Immunology, 2016
- Effect of Prednisolone Administration on Patients with Unexplained Recurrent Miscarriage and in Routine Intracytoplasmic Sperm Injection: A Meta‐AnalysisAmerican Journal of Reproductive Immunology, 2015